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Introduction
Patients who have been admitted to the intensive care unit for more than five days 
because of sepsis and multiorgan dysfunction and critical illness polyneuropathy 
are exposed to a high risk of morbidity and mortality (1). Polyneuropathy and 
myopathy are considered as the serious complications of critical illness. Sepsis, 
multiorgan dysfunction and hyperglycemia in admitted patients aggravate the 
polyneuropathy and myopathy and the attempt to prevent them has a significant 
role in reducing polyneuropathy and myopathy. Hyperglycemia developed by 
critical illness may continue for several days or may resolve in a few days (2, 3). In 
the patients affected by sepsis and multiorgan dysfunction, the peripheral nervous 
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Abstract
Objective 
Hyperglycemia may occur in the patients affected by any kind of critical illness. 
This complication makes an adverse effect on the clinical outcome of these 
patients by causing polyneuropathy and myopathy. It has been recently shown 
that treatment of hyperglycemia with insulin administration significantly reduces 
the prevalence of critical illness polyneuropathy and myopathy (CIPNM) and 
on the other hand reduces the demand for long-term mechanical ventilation in 
the patients admitted to the ICU for more than 1 week. The aim of this study 
was to determine the therapeutic effect of insulin in reducing the incidence of 
CIPNM in the pediatric intensive care unit (PICU).
Materials & Methods 
In this study, we recruited 30 patients admitted to the PICU of Tabriz Pediatric 
Hospital. The incidence of CIPNM following hyperglycemia was evaluated in 
these patients. The patients were categorized into two groups. In the case group, 
blood sugar was controlled in the range of 140-180mg/dl by administration of 
0.05 unit per kilogram body weight of insulin as drip protocol in an hour and in 
the control group, placebo was used. Consequently, the incidence of CIPNM, 
duration of PICU and duration of mechanical ventilation were compared 
between the two groups.
Results 
The incidence of CIPNM and duration of PICU stay and mechanical ventilation 
were significantly reduced in the patients treated with insulin compared to the 
control group.
Conclusion
This study shows that blood sugar control decreases the incidence of CIPNM.
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system is one of the systems that may be involved. The 
result of this diffused peripheral neuropathy has been 
nominated as critical illness polyneuropathy (2). Nerve 
conduction studies in the patients affected by sepsis and 
multiorgan dysfunction have demonstrated sensory and 
motor polyneuropathy in 70 percent of the patients (4). 
These problems are hidden in most of the patients, but 
in some cases they may cause severe weakness in the 
extremities and the trunk (5).
In a 24-month observational study, 57 patients who 
were admitted to the intensive care unit of Tabriz 
children hospital and were mechanically ventilated for 
at least one week were recruited. Based on clinical and 
electrodiagnostic findings, critical illness polyneuropathy 
and myopathy (CIPNM) was diagnosed in 13 patients 
(22.8%). In this study, hyperglycemia as one of the 
CIPNM causing factors was analyzed. Hyperglycemia 
may occur in patients affected by any critical illness 
and may cause an adverse effect in the outcome of these 
patients. It has been shown recently that treatment with 
insulin significantly reduces the prevalence of CIPNM. 
On the other hand, it reduces the demand for long-term 
ventilation in patients who are admitted to the ICU for 
more than 1 week (6). Therefore, with regard to the 
limited studies investigating the therapeutic effects 
of insulin in reducing CIPNM in children and also to 
prevent acquired paresis unrelated to the central nervous 
system diseases, this study assessed the important role 
of insulin therapy in CIPNM.
Materials & Methods
We conducted an interventional study (a clinical 
trial) and evaluated 30 patients admitted to the PICU 
of Tabriz Pediatric Educational Therapeutic Center 
from August 2011 to February 2012. In 18 months, 
30 patients who were admitted to the PICU and had 
received mechanical ventilation for at least 1 week 
and had developed hyperglycemia (BS>180 mg/dl) 
during their hospitalization were recruited. The effect 
of hyperglycemia on the incidence of CIPNM was 
evaluated.
Patients with spinal lesions, Guillain-Barre syndrome, 
myasthenia gravis, hypophosphatemia, patients who 
developed nervous system disorders and complications 
during their hospitalization, patients with confirmed 
neuromuscular diseases that caused weakness and 
paralysis, patients with a blood sugar level higher than 
250 mg/dl and patients with known metabolic disorders 
were excluded from the study.
Patients who were enrolled into the study were 
categorized into two groups. In the first group insulin 
was administrated to 15 patients who were under 
mechanical ventilation in order to maintain blood sugar 
in the range of 140-180 mg/dl. In the other group (the 
other15 patients), placebo was used instead. These 
patients were continuously examined during their 
hospitalization and the status of their deep tendon 
reflexes and weakness was evaluated. In each patient 
suspicious of polyneuropathy and myopathy, EMG 
and NCV was conducted at earliest convenience after 
weaning from the ventilator.
NCV of motor nerves (tibial, peroneal and median) and 
sensory nerves (soral, median, f wave of tibial and ulnar 
nerves) and EMG of the proximal and distal muscles of 
the lower and upper extremities were performed. On the 
basis of the results of EMG and NCV in the two above-
mentioned groups, the intensity of polyneuropathy 
and myopathy was classified into three categories: 1. 
Sensory loss in the lower limbs (mild) 2. Sensory-motor 
loss in the lower limbs and sensory loss in the upper 
limb (moderate) 3. Sensory-motor loss in the lower and 
upper limbs (severe).
The treatment protocol was continuous administration 
of 0.05 unit per kilogram of body weight insulin as drip 
infusion in an hour and serial control of blood sugar 
every hour with the aim of maintenance of blood sugar 
in the range of 140-180mg/dl. When the blood glucose 
level fell below the targeted range, insulin therapy was 
stopped.
This study was approved by the Ethics Committee of 
Tabriz University of Medical Sciences and the Iranian 
registry for clinical trials (IRCT). The clinical trial 
number was 201108117295 N1. Written consent was 
obtained from the parents and patient information was 
kept confidential.
Data were analyzed using SPSS 13 for Windows 
(SPSS Inc., Chicago, Illinois, USA). The quantitative 
variables (mean days of PICU stay and the mean time 
of mechanical ventilation) were compared using the 
Mann-Whitney U test. The quantitative variables were 
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treated with insulin and 50.5% in the control group (6).
Besides, in another study they showed that control of 
blood sugar by daily administration of insulin in the 
ICU would have a positive effect on the neuromuscular 
function and would cause reduction in the incidence of 
CIPNM electrophysiologically (6).
In 2005, in a study conducted by Van den Berghe and 
colleagues, they showed that administration of insulin 
in order to prevent hyperglycemia in ICU kept the 
central and peripheral nervous system safe leading 
to shortening of ICU stay and consequently earlier 
remission after discharge (1).
All the studies mentioned above emphasize that there is 
no doubt that maintenance of blood sugar in the normal 
range reduces the incidence of CIPNM. The present 
study is in accordance with these findings. Hermans et 
al. (6) showed that the patients struggling with critical 
illnesses in the ICU are exposed to the risk of damage 
caused by hyperglycemia that is because of the passive 
offtake of glucose and reduction in the clearance of free 
oxygen radicals. They also propounded that prevention 
of hyperglycemia has a simple protective effect on the 
mitochondrial structure and function of the nervous 
system.
Maintenance of the normoglycemic state also reduces 
organ damage by vessel endothelium protection via 
reduction of nitric acid production. Administration of 
insulin itself would be beneficial in the patients admitted 
to the ICU by reducing inflammation and dyslipidemia 
(6).
In several studies, the target range for blood sugar has 
been mentioned as 80-110mg/dl and maintenance of 
blood sugar in this range has been the aim of insulin 
administration. However, in the two studies conducted 
by Wiener et al. and Griesdal et al., it was propounded 
that tight control of blood sugar did not affect mortality 
and it was associated with a high risk of hypoglycemia 
(7, 8).
In a study carried out by Mraovic in 2009, a higher 
mortality rate was detected in patients with a 81-108mg/
dl maintained blood sugar level than those with a 140-
180mg/dl target range of blood sugar. Hypoglycemia 
caused by tight control of blood sugar reduces the other 
profits of blood sugar control (9). In our study, because 
the patients were children and that children are more 
compared using the chi-square test. A p value ≥ 0.05 
was considered statistically significant. The data were 
presented as mean ± SD, frequency and percentage 
values.
Results
The patients had an age range between 1 month to 12 
years. Of the 30 patients recruited in this study, 15 
patients were treated with insulin and placebo was used 
for the other 15 patients. Of the 15 patients treated with 
insulin, CIPNM was diagnosed in six patients (40%) 
and nine patients did not show CIPNM (60%). Of the 
15 patients in the control group, CIPNM was diagnosed 
in 11 cases (73.3%) and four cases did not have CIPNM 
(26.7%). There was a statistically significant intergroup 
difference in the incidence of CIPNM (p=0.023).
The mean duration of ICU stay was 15.13 days in 
the patients treated with insulin and 19.73 days in 
the control group indicating a statistically significant 
difference in the duration of ICU stay between the two 
groups (p>0.001). In the insulin administered group, 
the duration of mechanical ventilation was 12.87±2.13 
days and in the control group this figure was 16.33±2.71 
days. There was a significant difference in the duration 
of mechanical ventilation between the two groups 
(p>0.001).
The mean PRISM (Pediatric Risk of Mortality) score 
was 15.7±3.28 in the group treated with insulin 
and 16.93±2.78 in the control group. There was no 
significant difference statistically in the PRISM score 
between the two groups at the time of admission to the 
PICU (p=0.18).
Discussion
In the present study, hyperglycemia was evaluated as 
one of the important factors causing CIPNM in the 
ICU of Tabriz Pediatric Hospital. Of the 30 evaluated 
patients, CIPNM was diagnosed in six patients (40%) 
of the insulin treated group and 11 cases of the control 
group (73.3%).
In a study conducted by Hermans and colleagues, they 
concluded that controlling blood sugar by administration 
of insulin in ICU patients reduced the incidence of 
CIPNM compared to the control group. In their study, 
the incidence of CIPNM was 38.9% in the patients 
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more complications, the demand for ICU admission 
will increase.
Comparison of PRISM score between the two groups at 
the time of PICU admission was another objective that 
was evaluated alongside the above mentioned matters. 
The patients who had a PRISM score below 9 and a 
PRISM score higher than 30 were excluded from the 
study. The patients who had a PRISM score below 9 
were cases who did not need mechanical ventilation 
for more than 7 days and were spontaneously excluded 
from our study. With regard to the point that in patients 
with a PRISM score higher than 3, factors other than 
hyperglycemia could lead to polyneuropathy and 
myopathy, these patients were excluded. The patients 
with a PRISM score between 10 and 29 were included. 
There was no significant difference in the PRISM 
score at the time of PICU admission between the two 
groups. Since CIPNM is a multifactorial disease, it is 
recommended to evaluate the other factors separately 
in other studies.
In conclusion, this study shows that controlling blood 
sugar reduces the incidence of CIPNM, leading to 
shortening of the duration of mechanical ventilation, 
ICU stay and finally hospitalization.
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